Nathan Markward, PhD

Nathan leads the conceptualization, execution, and delivery of comparative effectiveness, HEOR, performance improvement, and risk adjustment studies that drive opportunity identification and value creation for a diverse array of clients, including biopharmaceutical companies, device manufacturers, health plans, provider networks, patient advocacy groups, and medical societies.

Nathan is a seasoned quantitative scientist with more than 20 years of research, consulting, and management experience in academia, biotechnology, and healthcare. He has a strong background in real-world study design, theoretical and applied statistics, and the deployment of data mining tools, predictive models, and AI/machine learning algorithms in the context of health system operations, population health program evaluation, precision medicine product development, and value-based contracting.

Prior to joining Inovalon, Nathan held advanced analytics leadership roles at Ochsner Health Network, RxAnte, UnitedHealth Group, Medco Health Solutions, and Express Scripts, as well as faculty and research appointments at Louisiana State University (LSU), Pennington Biomedical Research Center, Sirius Genomics, and Sequenom.

Nathan holds a BS in health planning and administration from the University of Illinois at Urbana-Champaign, an MPH in epidemiology from Tulane University, and a PhD in human genetics and measurement theory from LSU. He has also completed doctoral training in biostatistics, health policy, and epidemiology—molecular, psychiatric, and veterinary—at UIUC and the Johns Hopkins University, respectively, and a post-doctoral fellowship in statistical genetics at the Hayward Genetics Center.